221 related articles for article (PubMed ID: 2320569)
1. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors.
Dennis MS; Henzel WJ; Pitti RM; Lipari MT; Napier MA; Deisher TA; Bunting S; Lazarus RA
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2471-5. PubMed ID: 2320569
[TBL] [Abstract][Full Text] [Related]
2. Decorsin. A potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora.
Seymour JL; Henzel WJ; Nevins B; Stults JT; Lazarus RA
J Biol Chem; 1990 Jun; 265(17):10143-7. PubMed ID: 2351655
[TBL] [Abstract][Full Text] [Related]
3. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
Rahman S; Lu X; Kakkar VV; Authi KS
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
[TBL] [Abstract][Full Text] [Related]
4. Ornatins: potent glycoprotein IIb-IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella ornata.
Mazur P; Henzel WJ; Seymour JL; Lazarus RA
Eur J Biochem; 1991 Dec; 202(3):1073-82. PubMed ID: 1765068
[TBL] [Abstract][Full Text] [Related]
5. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
6. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
7. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM
J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698
[TBL] [Abstract][Full Text] [Related]
8. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
9. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
10. Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon halys brevicaudus) venom.
Kang IC; Chung KH; Lee SJ; Yun Y; Moon HM; Kim DS
Thromb Res; 1998 Jul; 91(2):65-73. PubMed ID: 9722022
[TBL] [Abstract][Full Text] [Related]
11. An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function.
Deckmyn H; Stanssens P; Hoet B; Declerck PJ; Lauwereys M; Gansemans Y; Tornai I; Vermylen J
Br J Haematol; 1994 Jul; 87(3):562-71. PubMed ID: 7993797
[TBL] [Abstract][Full Text] [Related]
12. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata.
Karczewski J; Endris R; Connolly TM
J Biol Chem; 1994 Mar; 269(9):6702-8. PubMed ID: 8120028
[TBL] [Abstract][Full Text] [Related]
13. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: analysis by site-directed mutagenesis.
Dennis MS; Carter P; Lazarus RA
Proteins; 1993 Mar; 15(3):312-21. PubMed ID: 8456099
[TBL] [Abstract][Full Text] [Related]
14. Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins.
McDowell RS; Dennis MS; Louie A; Shuster M; Mulkerrin MG; Lazarus RA
Biochemistry; 1992 May; 31(20):4766-72. PubMed ID: 1591238
[TBL] [Abstract][Full Text] [Related]
15. Sequential 1H NMR assignments of kistrin, a potent platelet aggregation inhibitor and glycoprotein IIb-IIIa antagonist.
Adler M; Wagner G
Biochemistry; 1992 Feb; 31(4):1031-9. PubMed ID: 1734953
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
Okuda D; Morita T
J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017
[TBL] [Abstract][Full Text] [Related]
17. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets.
Huang TF; Holt JC; Kirby EP; Niewiarowski S
Biochemistry; 1989 Jan; 28(2):661-6. PubMed ID: 2653425
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of platelet aggregation inhibitors from snake venoms.
Trikha M; Rote WE; Manley PJ; Lucchesi BR; Markland FS
Thromb Res; 1994 Jan; 73(1):39-52. PubMed ID: 8178312
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
Foster MR; Hornby EJ; Brown S; Hann M; Kitchin J; Pike N; Ward P
Thromb Res; 1994 Aug; 75(3):269-84. PubMed ID: 7992238
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
Imura Y; Stassen JM; Bunting S; Stockmans F; Collen D
Blood; 1992 Sep; 80(5):1247-53. PubMed ID: 1515641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
